Home › Funds › WAYCROSS PARTNERS, LLC › GILD

WAYCROSS PARTNERS, LLC position in GILD

GILEAD SCIENCES INC · Health Care

WAYCROSS PARTNERS, LLC reported holding 5,732 shares of GILD (GILEAD SCIENCES INC) in its Q2 2026 13F filing — a position valued at US$724K, representing 0.06% of its reported portfolio and ranking #38 among its reported holdings. WAYCROSS PARTNERS, LLC has disclosed GILD holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)5.73K sh
Reported value held$724.18K
Portfolio Weight0.06%
First reportedQ2 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How WAYCROSS PARTNERS, LLC's GILD position evolved

WAYCROSS PARTNERS, LLC first disclosed a stake in GILD in Q2 2025 at 5,732 shares (US$636K). The position peaked in Q1 2026 at 5,732 shares, worth US$799K. Across 5 filings, WAYCROSS PARTNERS, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 5,732 shares valued at US$724K.

Quarter by quarter

QuarterSharesValueChange
Q2 2025 5.73K $635.51K New
Q3 2025 5.73K $636.25K Hold
Q4 2025 5.73K $703.55K Hold
Q1 2026 5.73K $798.87K Hold
Q2 2026 5.73K $724.18K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has WAYCROSS PARTNERS, LLC held GILD?

WAYCROSS PARTNERS, LLC has disclosed GILD holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is WAYCROSS PARTNERS, LLC's current position in GILD?

As of Q2 2026, WAYCROSS PARTNERS, LLC holds 5.73K shares of GILD (GILEAD SCIENCES INC), valued at $724.18K, representing 0.06% of its reported portfolio and ranking #38.

Has WAYCROSS PARTNERS, LLC been buying or selling GILD?

In the latest 13F filing (Q2 2026), WAYCROSS PARTNERS, LLC held unchanged its position in GILD. The position peaked in Q1 2026 at 5.73K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.